ad

3 Customer Services Outsourcing Company, Chlor Alkali Maker and Regional Hospitals Chain Stocks With a Strong Future Roadmap: Firstsource Solutions, DCM Shriram and Krishna Institute of Medical Sciences

Firstsource Solutions, DCM Shriram and Krishna Institute of Medical Sciences: ROE of 10.7% to 17.1% and FY22 to FY26 revenue CAGR of 9.0% to 23.8%. Prices as of 13 Nov 2026.


16 Nov 2026 • 2:28 pm

3 Customer Services Outsourcing Company, Chlor Alkali Maker and Regional Hospitals Chain Stocks With a Strong Future Roadmap: Firstsource Solutions, DCM Shriram and Krishna Institute of Medical Sciences

Quick Answer

The three customer service, chemical and hospital stocks to watch are Firstsource Solutions, DCM Shriram and Krishna Institute of Medical Sciences. Their return on equity ranges from 10.7% to 17.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.0% to 23.8%. Firstsource Solutions has the highest return on equity at 17.1%, while Krishna Institute of Medical Sciences has the fastest revenue growth at 23.8% a year. Prices are based on the 13 November 2026 close, and this article is educational, not investment advice.

Customer service, chemical and hospital stocks offer a focused view of a sector where demand keeps widening. Firstsource Solutions, DCM Shriram and Krishna Institute of Medical Sciences cover a customer services outsourcing company, a chlor alkali maker and a regional hospitals chain.

This list covers three customer service, chemical and hospital stocks with complete current figures: Firstsource Solutions, DCM Shriram and Krishna Institute of Medical Sciences. Every figure comes from the latest reported financials and the 13 November 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Customer Service, Chemical and Hospital Stocks?

Customer service, chemical and hospital stocks are listed companies that provide customer service and back office outsourcing to global clients, make chlor alkali, plastics and other industrial products, and run hospitals in growing regional cities. Their earnings depend on client outsourcing, chemical demand and patient volumes.

Customer Service, Chemical and Hospital Stocks at a Glance

Company CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE (%) D/E
Firstsource Solutions 291.25 19,489 29.1 17.5 17.1 0.67
DCM Shriram 896.95 14,257 10.3 13.9 16.3 0.24
Krishna Institute of Medical Sciences 729.65 28,495 146.5 59.6 10.7 1.89

On valuation, DCM Shriram trades at a P/E below the industry P/E, while Firstsource Solutions and Krishna Institute of Medical Sciences trade above it, which reflects the growth the market already expects. Readers comparing customer service, chemical and hospital stocks should look at return on equity and debt together, since a high return earned with low debt is easier to sustain.

Why Do Customer Service, Chemical and Hospital Stocks Have a Strong Roadmap in India?

Customer service, chemical and hospital stocks have a strong roadmap in India because growing outsourcing of customer work, steady industrial demand and rising access to hospital care in smaller cities keep widening the market for these companies.

  • Customer services. Global firms outsource service work.
  • Chlor alkali. Industry needs core chemical inputs.
  • Regional hospitals. Smaller cities need more quality care.

Why Firstsource Solutions Features Among These Customer Service, Chemical and Hospital Stocks

Among the customer service, chemical and hospital stocks on this list, Firstsource Solutions, an RPG group company, is a business process management firm serving banks, healthcare payers and providers, and other clients, mainly in the United States and the United Kingdom.

Revenue rose from Rs 5,922 crore in FY22 to Rs 9,564 crore in FY26, a compound annual growth rate of 12.7%. Net profit grew from Rs 537 crore in FY22 to Rs 674 crore in FY26, which works out to a compound annual growth rate of 5.9%.

In the June 2026 quarter, revenue grew 22.8% year on year to Rs 2,731 crore. The company has a return on equity of 17.1%, a debt to equity ratio of 0.67 and a market capitalisation of Rs 19,489 crore. The stock trades at a P/E of 29.1, above the industry P/E of 17.5.

Roadmap: It is growing in healthcare and mortgage services, pursuing larger deals and using artificial intelligence to improve productivity. Longer contracts with large clients give it visibility on revenue.

What to watch: Follow contract wins in healthcare and the pace of new technology investments.

Why DCM Shriram Features Among These Customer Service, Chemical and Hospital Stocks

Among the business process, caustic soda and medical care shares on this list, DCM Shriram is a diversified company with businesses in caustic soda and chemicals, sugar, fertilisers and agri inputs, and building products.

Revenue rose from Rs 9,719 crore in FY22 to Rs 13,734 crore in FY26, a compound annual growth rate of 9.0%. Net profit grew from Rs 447 crore in FY24 to Rs 856 crore in FY26, which works out to a compound annual growth rate of 38.4%.

The company has a return on equity of 16.3%, a debt to equity ratio of 0.24 and a market capitalisation of Rs 14,257 crore. The stock trades at a P/E of 10.3, below the industry P/E of 13.9.

Roadmap: The company is expanding its chemicals capacity and widening its range of agri inputs and value-added products. A mix of chemicals and agri businesses spreads its sources of revenue.

What to watch: Monitor chemical prices, sugar output and demand for agri inputs.

Why Krishna Institute of Medical Sciences Features Among These Customer Service, Chemical and Hospital Stocks

Among the three companies on this list, Krishna Institute of Medical Sciences, known as KIMS Hospitals, runs a network of multi-specialty hospitals in Telangana, Andhra Pradesh and other states, with strengths in cardiac, neuro and transplant care.

The company has a return on equity of 10.7%, a debt to equity ratio of 1.89 and a market capitalisation of Rs 28,495 crore. The stock trades at a P/E of 146.5, above the industry P/E of 59.6.

Revenue rose from Rs 1,671 crore in FY22 to Rs 3,931 crore in FY26, a compound annual growth rate of 23.8%. Net profit for FY26 was Rs 242 crore, a net margin of 6.2%. In the June 2026 quarter, revenue grew 36.1% year on year to Rs 1,196 crore.

Roadmap: The company is adding beds in existing clusters and opening hospitals in new cities across southern and central India. Rising insurance cover and demand for advanced procedures support growth in patient volumes.

What to watch: Track bed additions, occupancy and revenue per occupied bed.

Firstsource Solutions vs DCM Shriram vs Krishna Institute of Medical Sciences on Key Financials

The table below sets the three customer service, chemical and hospital stocks side by side on revenue, profit and margin, using reported figures.

Company FY22 Revenue (Rs Cr) FY26 Revenue (Rs Cr) Revenue CAGR (FY22-FY26) FY26 Net Profit (Rs Cr) FY26 Net Margin
Firstsource Solutions 5,922 9,564 12.7% 674 7.1%
DCM Shriram 9,719 13,734 9.0% 856 6.2%
Krishna Institute of Medical Sciences 1,671 3,931 23.8% 242 6.2%

Firstsource Solutions posts the highest return on equity in this group at 17.1%. DCM Shriram has the largest FY26 revenue at Rs 13,734 crore, and Krishna Institute of Medical Sciences shows the fastest revenue growth with a 23.8% compound annual rate. A useful habit with customer service, chemical and hospital stocks is to check each new quarterly result against the capacity plans the company described earlier.

Key Risks to Check Before Investing in Customer Service, Chemical and Hospital Stocks

Every theme carries risks that deserve a check before any decision. For these customer service, chemical and hospital stocks, the main points are: Long-term business process, caustic soda and medical care shares holders usually track revenue growth, margins and cash flow side by side rather than relying on a single ratio.

  • Currency moves. Export earnings move with the rupee.
  • Raw material and energy costs. Input prices can move margins in chemicals.
  • Capacity ramp up. New hospitals take time to fill beds and reach full returns.

Treat this list as a starting point for research and not as a recommendation. Read the latest results presentation, check the management commentary on order books or capacity plans, and compare each company with its peers before you decide anything.

Use the Univest Stock Screener to filter customer service, chemical and hospital stocks by market capitalisation, P/E, ROE and growth, and build your own shortlist.

Final Thoughts on Customer Service, Chemical and Hospital Stocks

Customer service, chemical and hospital stocks reward patient research into demand, execution and financial strength. Firstsource Solutions, DCM Shriram and Krishna Institute of Medical Sciences each have a clear plan to grow. Based on the 13 November 2026 close, Firstsource Solutions trades at Rs 291.25, DCM Shriram at Rs 896.95 and Krishna Institute of Medical Sciences at Rs 729.65.

Download the Univest iOS App or Univest Android App to track customer service, chemical and hospital stocks, set price alerts and get research-backed stock ideas.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

What are customer service, chemical and hospital stocks?

Ans. Customer service, chemical and hospital stocks are listed companies that provide customer service and back office outsourcing to global clients, make chlor alkali, plastics and other industrial products, and run hospitals in growing regional cities. Their earnings depend on client outsourcing, chemical demand and patient volumes. This list looks at three of them, Firstsource Solutions, DCM Shriram and Krishna Institute of Medical Sciences, using reported FY22 to FY26 financials and the 13 November 2026 closing prices.

Which customer service, chemical and hospital stocks are covered in this list?

Ans. This list covers Firstsource Solutions, DCM Shriram and Krishna Institute of Medical Sciences. Based on the 13 November 2026 close, Firstsource Solutions traded at Rs 291.25, DCM Shriram at Rs 896.95 and Krishna Institute of Medical Sciences at Rs 729.65. Their return on equity ranges from 10.7% to 17.1%, and their revenue compound annual growth from FY22 to FY26 ranges from 9.0% to 23.8%.

Why do customer service, chemical and hospital stocks have a strong future roadmap in India?

Ans. Customer service, chemical and hospital stocks have a strong roadmap in India because growing outsourcing of customer work, steady industrial demand and rising access to hospital care in smaller cities keep widening the market for these companies. The main drivers are as follows. Customer services. Global firms outsource service work. Chlor alkali. Industry needs core chemical inputs. Regional hospitals. Smaller cities need more quality care. Together these factors give the companies on this list a visible path for growth over the coming years.

How has Firstsource Solutions performed financially?

Ans. Revenue rose from Rs 5,922 crore in FY22 to Rs 9,564 crore in FY26, a compound annual growth rate of 12.7%. Net profit grew from Rs 537 crore in FY22 to Rs 674 crore in FY26, which works out to a compound annual growth rate of 5.9%. In the June 2026 quarter, revenue grew 22.8% year on year to Rs 2,731 crore. The company has a return on equity of 17.1%, a debt to equity ratio of 0.67 and a market capitalisation of Rs 19,489 crore. The stock trades at a P/E of 29.1, above the industry P/E of 17.5. Looking ahead, it is growing in healthcare and mortgage services, pursuing larger deals and using artificial intelligence to improve productivity. Longer contracts with large clients give it visibility on revenue.

How has DCM Shriram performed financially?

Ans. Revenue rose from Rs 9,719 crore in FY22 to Rs 13,734 crore in FY26, a compound annual growth rate of 9.0%. Net profit grew from Rs 447 crore in FY24 to Rs 856 crore in FY26, which works out to a compound annual growth rate of 38.4%. The company has a return on equity of 16.3%, a debt to equity ratio of 0.24 and a market capitalisation of Rs 14,257 crore. The stock trades at a P/E of 10.3, below the industry P/E of 13.9. Looking ahead, the company is expanding its chemicals capacity and widening its range of agri inputs and value-added products. A mix of chemicals and agri businesses spreads its sources of revenue.

How has Krishna Institute of Medical Sciences performed financially?

Ans. Revenue rose from Rs 1,671 crore in FY22 to Rs 3,931 crore in FY26, a compound annual growth rate of 23.8%. Net profit for FY26 was Rs 242 crore, a net margin of 6.2%. In the June 2026 quarter, revenue grew 36.1% year on year to Rs 1,196 crore. The company has a return on equity of 10.7%, a debt to equity ratio of 1.89 and a market capitalisation of Rs 28,495 crore. The stock trades at a P/E of 146.5, above the industry P/E of 59.6. Looking ahead, the company is adding beds in existing clusters and opening hospitals in new cities across southern and central India. Rising insurance cover and demand for advanced procedures support growth in patient volumes.

What risks should investors check before buying customer service, chemical and hospital stocks?

Ans. Investors should check a few risks before buying customer service, chemical and hospital stocks. Currency moves. Export earnings move with the rupee. Raw material and energy costs. Input prices can move margins in chemicals. Capacity ramp up. New hospitals take time to fill beds and reach full returns. Reading the latest results presentation and comparing each company with its peers helps judge how these risks apply to each stock.

Is this list of customer service, chemical and hospital stocks investment advice?

Ans. No. This article is educational and uses publicly available data as of the 13 November 2026 close. Please verify figures on NSE and BSE, read company filings and consult a SEBI registered adviser before investing. Univest is SEBI registered research analyst INH000013776.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down